<div id="readability-page-1"><p>Accurate Wealth Management LLC boosted its stake in shares of  McKesson Corporation (NYSE:MCK - Free Report) by 463.6% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor  owned 3,928 shares of the company's stock after purchasing an additional 3,231 shares during the period. Accurate Wealth Management LLC's holdings in McKesson were worth $3,071,000 at the end of the most recent reporting period.</p><ul><li>More Than Yield: 5 Stocks Beating the Market and Hiking Dividends</li></ul><p>Several other large investors have also recently added to or reduced their stakes in MCK. Miracle Mile Advisors LLC grew its holdings in shares of  McKesson by 114.1% during the 3rd quarter. Miracle Mile Advisors LLC now owns 1,933 shares of the company's stock valued at $1,493,000 after acquiring an additional 1,030 shares in the last quarter.  IAM Advisory LLC raised its holdings in shares of  McKesson by 0.3% during the third quarter. IAM Advisory LLC now owns 3,908 shares of the company's stock worth $3,019,000 after acquiring an additional 13 shares in the last quarter.  Allspring Global Investments Holdings LLC boosted its position in  McKesson by 475.4% during the third quarter. Allspring Global Investments Holdings LLC now owns 152,557 shares of the company's stock valued at $116,718,000 after purchasing an additional 126,043 shares during the last quarter.  Merit Financial Group LLC grew its stake in  McKesson by 3.0% in the third quarter. Merit Financial Group LLC now owns 18,210 shares of the company's stock valued at $14,068,000 after purchasing an additional 532 shares in the last quarter.  Finally, Calamos Wealth Management LLC increased its position in  McKesson by 0.5% in the 3rd quarter. Calamos Wealth Management LLC now owns 5,384 shares of the company's stock worth $4,159,000 after purchasing an additional 28 shares during the last quarter. Institutional investors and hedge funds own  85.07% of the company's stock. </p><h2>McKesson Price Performance</h2><p>MCK stock opened at $820.18 on Thursday. The stock has a market capitalization of $101.23 billion, a price-to-earnings ratio of 25.53, a price-to-earnings-growth ratio of 1.36 and a beta of 0.38. The company has a 50-day moving average of $832.73 and a two-hundred day moving average of $757.90. McKesson Corporation has a 52-week low of $565.75 and a 52-week high of $895.58. </p><ul><li>3 Safe Dividend Stocks as Investors Seek to Reset Diversification</li></ul><p>McKesson (NYSE:MCK - Get Free Report) last posted its quarterly earnings data on Wednesday, November 5th. The company reported $9.86 EPS for the quarter, topping analysts' consensus estimates of $8.84 by $1.02. McKesson had a negative return on equity of 248.14% and a net margin of 1.04%.The business had revenue of $103.15 billion for the quarter, compared to analyst estimates of $103.80 billion. During the same period in the previous year, the company posted $7.07 earnings per share. The firm's revenue for the quarter was up 10.2% on a year-over-year basis.  Equities analysts expect that  McKesson Corporation will post 32.77 EPS for the current fiscal year. </p><h2>McKesson Dividend Announcement</h2><p>The firm also recently declared a quarterly dividend, which will be paid on Friday, January 2nd. Stockholders of record on Monday, December 1st will be issued a dividend of $0.82 per share. The ex-dividend date is Monday, December 1st. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. McKesson's payout ratio is 10.21%. </p><h2>Insider Buying and Selling at McKesson</h2><ul><li> 3 Stocks to Consider With a Possible Recession on the Table</li></ul><p>In other news, CAO Napoleon B. Rutledge, Jr. sold 329 shares of the firm's stock in a transaction on Friday, November 7th. The shares were sold at an average price of $861.63, for a total value of $283,476.27. Following the sale, the chief accounting officer owned 328 shares in the company, valued at approximately $282,614.64. This trade represents a 50.08% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own  0.08% of the company's stock. </p><h2>Analysts Set New Price Targets</h2><p>Several brokerages have recently issued reports on MCK. Jefferies Financial Group lifted their price target on McKesson from $820.00 to $900.00 and gave the company a &#34;buy&#34; rating in a report on Monday, October 13th. Citigroup raised their price objective on shares of McKesson from $820.00 to $860.00 and gave the company a &#34;buy&#34; rating in a research report on Wednesday, September 24th. Robert W. Baird lifted their target price on shares of McKesson from $873.00 to $927.00 and gave the company an &#34;outperform&#34; rating in a research note on Thursday, November 6th. Morgan Stanley boosted their target price on shares of McKesson from $857.00 to $916.00 and gave the stock an &#34;overweight&#34; rating in a research report on Thursday, November 6th. Finally, Evercore ISI  restated an &#34;outperform&#34; rating and set a $1,000.00 price target on shares of McKesson in a research note on Thursday, November 6th. Two research analysts have rated the stock with a Strong Buy rating, twelve have issued  a Buy rating and four have issued  a Hold rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $892.86.</p><p><b>View Our Latest Stock Analysis on McKesson</b></p><h2>McKesson Company Profile</h2> (Free Report)<p>McKesson Corporation <span>NYSE: MCK<span></span></span> is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.  </p><p>The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.</p><h2>See Also</h2><ul><li>Five stocks we like better than McKesson</li><li>The Best $1 You'll Spend This Holiday Season</li><li>Holiday surprise: $1 gets you everything</li><li>America’s “most deplorable” Christmas sale</li><li>Market Panic: Trump Just Dropped a Bomb on Your Stocks</li><li>Your family's wealth expires in 2026?</li></ul><p><strong>Want to see what other hedge funds are holding MCK?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1DSw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1DSw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in McKesson Right Now?</h2><p>Before you consider McKesson, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and McKesson wasn't on the list.</p><p>While McKesson currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Accurate Wealth Management LLC increased its stake in McKesson Corporation (NYSE:MCK) by 463.6% in Q3, owning 3,928 shares valued at $3.07 million. Other investors also raised their stakes, with institutional investors holding 85.07% of the stock. McKesson reported $9.86 EPS for the quarter, exceeding estimates, and declared a quarterly dividend of $0.82 per share. Analysts have set new price targets, with Jefferies raising theirs to $900.00 and Robert W. Baird to $927.00, maintaining a "buy" and "outperform" rating respectively.</p>

Accurate Wealth Management LLC Has $3.07 Million Position in McKesson Corporation $MCK